Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Ion Asset Management Stephen Levey And Jonathan Half | 38,347,875 | $642,710,385 | -2% | 35.34% |
| 2. | Rubric Capital Management David Rosen | 26,000,000 | $435,760,000 | +2% | 6.58% |
| 3. | Point State Capital Zach Schreiber | 20,712,398 | $347,139,790 | +37% | 5.29% |
| 4. | Glenview Capital Larry Robbins | 15,824,223 | $265,213,977 | +8% | 7.43% |
| 5. | Viking Global Andreas Halvorsen | 11,681,333 | $195,779,141 | +16% | 0.57% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.60 | 104,500 | $1,003,409.00 | 220,442 | 2019-06-04 | Filing | |
| $8.98 | 111,000 | $997,013.10 | 115,942 | 2019-06-03 | Filing | |
| $21.92 | 2,000 | $43,840.00 | 6,445 | 2018-08-03 | Filing | |
| $19.32 | 250,000 | $4,829,700.00 | 1,500,000 | 2018-05-10 | Filing | |
| $19.21 | 500,000 | $9,603,150.00 | 1,250,000 | 2018-05-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.16 | 6,053 | $91,748.35 | 6,774 | 2025-08-01 | Filing | |
| $15.16 | 52,742 | $799,436.87 | 0 | 2025-08-01 | Filing | |
| $17.08 | 55,775 | $952,464.10 | 403,288 | 2025-06-12 | Filing | |
| $17.02 | 6,206 | $105,627.98 | 9,989 | 2025-06-03 | Filing | |
| $18.04 | 337,915 | $6,097,304.47 | 150,996 | 2025-05-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 58,135,616 | $974,352,932 | 0.05% | |
| 2. | 54,318,382 | $910,376,088 | 0.02% | |
| 3. | 38,493,294 | $645,147,607 | 3.71% | |
| 4. | 37,761,444 | $632,881,581 | 8.35% | |
| 5. | 28,156,918 | $471,909,946 | 10.03% |
News See All
Leader Capital Markets Reiterates a Buy Rating on Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the top cheap pharmaceutical stocks to buy now.
11 Cheap Pharmaceutical Stocks to Buy Now
The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the steps they should take to decrease the prices of US prescription drugs to “most...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2025 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2025 Earnings Call Transcript July 30, 2025Teva Pharmaceutical Industries Limited misses on earnings expectations.
Leader Capital Markets Remains Bullish on Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy healthcare stocks to buy now.
10 Best Strong Buy Healthcare Stocks to Buy Now
On July 21, Jared Holz, Mizuho health care sector strategist, appeared on CNBC's 'The Exchange' to talk about whether any opportunity plays exist within the healthcare sector, and what pains the sector...
Teva Partners with Fosun Pharma to Advance Novel Cancer Immunotherapy TEV-56278
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts.
Teva's Ajovy Shows Sustained Long-Term Efficacy in Migraine Prevention Trial
Teva Pharmaceutical (NYSE:TEVA) is one of the most undervalued large cap stocks to buy according to analysts.
16 Most Promising Stocks According to Wall Street Analysts
On July 3, Scott Wren, Wells Fargo senior global market strategist, and Adam Crisafulli, Vital Knowledge founder, joined 'Closing Bell Overtime' on CNBC to talk about the current market conditions.
13 Most Undervalued Large Cap Stocks to Buy According to Analysts
On July 3, Ben Preston, Portfolio Manager at Orbis Investments, appeared on CNBC to suggest that investors look past the constant political headlines and market volatility and find undervalued global ...
Billionaire Hedge Funds
